Skip to content

WINDTREE THERAPEUTICS INC /DE/

WINT

CIK 0000946486

← back to feed
Revenue (TTM)
$1.48M
+25.3% YoY Q3 Nov 2025
Net Income (TTM)
−$45.51M
+91.2% YoY Q3 Nov 2025
EPS Diluted (TTM)
−$0.60
−211.5% YoY Q3 Nov 2025
Gross Margin
37.1%
Q3 Nov 2025
Operating Margin
-2,212.2%
Q3 Nov 2025
Net Margin
-3,079.2%
Q3 Nov 2025
Free Cash Flow (TTM)
−$14.67M
Q3 Nov 2025
Cash
$204K
Q3 Nov 2025
Total Debt
$20.28M
Q3 Nov 2025
Shares Outstanding
33.71M sh
Q3 Nov 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings